USFDA inspection at Alembic completed without any observations: Gujarat

433
USFDA Inspection audit
USFDA Inspection

Last Updated on December 31, 2023 by The Health Master

VadodaraAlembic Pharmaceuticals said the United States Food and Drug Administration (USFDA) successfully completed the inspection of its derma facility located at Karakhadi in Vadodara, Gujarat, without any observations.

According to a company statement released, the inspection was done between March 6 and March 10 this year.

In December last year, Alembic announced that it received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDADesonide Cream, 0.05 per cent, an ointment used for the treatment of skin conditions.

According to a statement from the Vadodara-headquartered pharma firm, the ANDA was filed by Aleor Dermaceuticals (Aleor) which was amalgamated with Alembic.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US. Desonide Cream, 0.05 per cent, is a low-potency corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Alembic said it received a cumulative total of 178 ANDA approvals (155 final approvals and 23 tentative approvals) from USFDA.

An abbreviated new drug application (ANDA) is an application for a US generic drug approval for an existing licensed medication or approved drug. 

Alembic Pharmaceuticals, established in 1907, is an Indian multinational pharmaceutical company headquartered in Vadodara.

It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be one of the market leaders in macrolides segment of anti-infective drugs in India.

USFDA issues Form 483 with 4 observations to Indoco Remedies, Goa

USFDA issues Form 483 with 8 observations to Cipla for Pithampur facility

USFDA issues Form 483 with 2 observations to Laurus Labs for Visakhapatnam facility

USFDA issues 2 observations to Natco Pharma for Vizag facility

USFDA issues Form 483 with zero observation to Solara Active Pharma Sciences Vizag Facility

USFDA issues Form 483 with 9 observations to Indoco Remedies, Goa

CDSCO has approved 30 Medical Devices Testing Laboratories till now

USFDA gives nod for generic version of Famotidine tablets

New Antibacterial molecule discovered: IIT Researchers

USFDA gives approval for Lenalidomide capsules

IDMA urges IPC to revise DT for Soft Gelatin Capsules

USFDA approves Nasal spray for opioid overdose

Pharma Industry urged to report overcharging cases to NPPA

National Medical Commission aims to streamline Medical Education

Understanding DQ, IQ, PQ, and OQ in the Pharma Industry

Duties and responsibilities of QA person in Pharma Industry

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news